Navigation Links
Bioenergy Life Science Retains Xsto Solutions to Market D-Ribose
Date:12/11/2008

MINNEAPOLIS, Dec. 11 /PRNewswire/ -- Bioenergy Life Science -- The Ribose Company -- has announced that it has retained Xsto Solutions, LLC, to market Bioenergy D-Ribose(TM) in the Eastern U.S. D-Ribose is a naturally-occurring monosaccharide the body uses to stimulate the synthesis of adenosine triphosphate (ATP) -- an essential energy compound.

"Collaborating with Xsto Solutions will enhance our efforts toward expanding D-Ribose into the marketplace," said Kathy Lund, vice president marketing and sales of Bioenergy Life Science, Ribose Ingredient Division. "D-Ribose is already included in over 100 functional foods and beverages. Aligning ourselves with Xsto Solutions means that more companies will incorporate this natural energy booster."

"Bioenergy D-Ribose is perhaps the most important nutritional discovery of the decade," says Dan Murray, Xsto Solutions vice president of business development. "We're very excited about aggressively expanding the exposure of D-Ribose within the supplement, functional foods and sports nutrition industries."

Although ribose is produced by the body naturally to regulate the synthesis of ATP, it cannot be replenished fast enough during certain forms of demanding exercise. When added to foods and dietary supplements, ribose enhances the body's natural process of energy synthesis. It helps reduce the loss of energy during stress and accelerates energy and tissue recovery.

Bioenergy, which recently achieved GRAS (generally recognized as safe) status for D-Ribose from the U.S. Food and Drug Administration, has amassed a large body of scientific literature regarding uses of ribose for people across all age and health categories. The company has more than 40,000 customers for its proprietary Corvalen(R) products alone, and millions worldwide use Bioenergy D-Ribose in other functional foods like energy bars (Detour, FastFuel, Marathon) and beverages (SoBe Adrenaline Rush, Vitamin Water, Snapple Antioxidant Water).

Bioenergy, Inc. (http://www.bioenergy.com) is a privately held, Minneapolis-based life sciences company whose core technology lies in the development and commercialization of products based on the physiological benefits of D-Ribose for health and wellness. In addition to a pharmaceutical subsidiary, Bioenergy has two other companies. Bioenergy Life Science, Inc. manufactures and sells D-Ribose as an ingredient to nutraceutical firms for beverages and foods; as a medical food through doctors and clinics; and as a dietary supplement for energy recovery (reduces fatigue, muscle pain, soreness and stiffness following exercise). Viacell, LLC is developing technology related to the enhancement of blood components.

Xsto Solutions, LLC (http://www.xstosolutions.com), was established in 2004 and is headquartered in Morristown, New Jersey. Xsto's core focus is bringing a small number of new science-supported nutritional ingredients to the dietary supplement and functional food market. Xsto personnel have successfully and profitably launched new products, driving sales by acting as US-based sales and marketing partners. Xsto has also partnered with small-to medium-sized dietary supplement manufacturers to increase sales and marketing focus.


'/>"/>
SOURCE Bioenergy Life Science
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
2. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
3. Edwards Lifesciences to Present at the Bear Stearns 20th Annual Healthcare Conference
4. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
5. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
6. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
7. John B. Buse, MD, PhD of Chapel Hill, NC, Elected American Diabetes Association President, Medicine & Science
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. SAMHSA Announces First Science and Service Award Winners
10. Novavax CEO to Present at the 2007 UBS Global Life Sciences Conference
11. Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... , ... June 27, 2017 , ... DrugDev ... is whether they can trust the sponsor to pay them correctly and on time. ... and CROs establish payment strategies that encourage sites to work on their studies. , ...
(Date:6/27/2017)... , ... June 27, 2017 , ... The Congressional Budget ... to repeal and replace the 2010 Patient Protection and Affordable Care Act (ACA), would ... what would be expected under current law. , More than 20 million Americans have ...
(Date:6/27/2017)... ... June 27, 2017 , ... A January 18th article on ... staggering $6.81 billion by the year 2024 according to a new report. The article ... those made from titanium. Los Angeles area clinic Beverly Hills Periodontics & Dental Implant ...
(Date:6/27/2017)... York, NY (PRWEB) , ... June 27, 2017 ... ... and marketing experts to contribute to an upcoming case studies guidebook. This guidebook ... her organization. , This book will include articles, case studies and how-to’s that ...
(Date:6/27/2017)... CT (PRWEB) , ... June 27, 2017 , ... Dr. ... the recent renovation of his practice, Advanced Periodontics and Dental Implant Center of Connecticut. ... increased the administrative and waiting areas. The renovations are intended to improve patient comfort ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... , June 14, 2017  In 2016, ... Creative Startups pitch competition and came away with ... platform is described by Forbes as "entering the life ... Medical Association as teaching "empathy to medical professionals in ... startup was recently named a finalist for the Department ...
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/7/2017)... , June 7, 2017 Endo International plc ... 7, 2017, the Hon. Joseph R. Goodwin , ... West Virginia , entered a case ... Pelvic Repair System Products Liability Litigation (the "MDL") that ... cases to provide expert disclosures on specific causation within ...
Breaking Medicine Technology: